Article Recommendations for Immunogenicity and safety of a Recombinant gE-Fc Fusion Protein Subunit Vaccine for Herpes Zoster in Adults ≥50 Years of Age: a randomised, active-controlled, non-inferiority trial
The following articles have been recommended by
Semantic Scholar's
Paper Recommendations API
as related content to
Immunogenicity and safety of a Recombinant gE-Fc Fusion Protein Subunit Vaccine for Herpes Zoster in Adults ≥50 Years of Age: a randomised, active-controlled, non-inferiority trial
by
Related articles are currently not available for this article.